It has been reported that prostate stem cell antigen (PSCA) is overexpressed in certain cancer types and confers poor prognoses. The rs2294008 (C/T) polymorphism of PSCA is considered to be associated with risk for gastric, bladder, and colorectal cancers; however, these studies have produced inconsistent results, so we performed this meta-analysis to verify the association between the PSCA rs2294008 (C/T) polymorphism and cancer risk.
Methods:
A systematic literature search was performed using PubMed, EMBASE, and the Chinese National Knowledge Infrastructure, through October 20, 2022 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association between the PSCA rs2294008 (C/T) polymorphism and cancer risk. In addition, we explored PSCA mRNA expression in cancers through online tools.
Results:
In total, 45 articles met our inclusion criteria and were analyzed, including 37,586 cancer cases and 51,197 non-cancer controls. Except in the recessive model, the pooled effect indicated the PSCA rs2294008 T allele was associated with an increased overall cancer risk (T vs. C: OR = 1.120, 95% CI = 1.056-1.188, p < 0.01; TT vs. CC: OR = 1.206, 95% CI = 1.066-1.364, p = 0.03; CT vs. CC: OR = 1.249, 95% CI = 1.151-1.356, p < 0.01; [CT+TT] vs. CC: OR = 1.248, 95% CI = 1.147-1.359, p < 0.01; TT vs. [CT+CC]: OR = 1.051, 95% CI = 0.954-1.156, p = 0.314). In the subgroup analysis, there were significant associations between the rs2294008 T allele and increased risk of bladder and gastric cancer. Two different online tools were used to explore the PSCA mRNA levels in cancer and the corresponding normal adjacent tissues. We found that expression of PSCA was significantly lower in gastric cancer patients.
Conclusions:
The PSCA rs2294008 T polymorphism is related to increased cancer susceptibility, especially for gastric and bladder cancers. This polymorphism results in a decreased PSCA expression level in gastric cancer.
Get full access to this article
View all access options for this article.
References
1.
AlmozyanS, ColakD, MansourF, et al.PD-L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation. Int J Cancer, 2017; 141(7):1402-1412; doi: 10.1002/ijc.30834
2.
ArganiP, RostyC, ReiterRE, et al. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res, 2001; 61(11):4320-4324.
3.
BahrenbergG, BrauersA, JoostHG, et al.Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun, 2000; 275(3):783-788; doi: 10.1006/bbrc.2000.3393
4.
BerlauJ, GleiM, Pool-ZobelBL. Colon cancer risk factors from nutrition. Anal Bioanal Chem, 2004; 378(3):737-743; doi: 10.1007/s00216-003-2284-4
5.
CaiM, DaiS, ChenW, et al.Environmental factors, seven GWAS-identified susceptibility loci, and risk of gastric cancer and its precursors in a Chinese population. Cancer Med, 2017; 6(3):708-720; doi: 10.1002/cam4.1038
6.
CuiH, TangM, ZhangMet al. (2019) Variants in the PSCA gene associated with risk of cancer and nonneoplastic diseases: Systematic research synopsis, meta-analysis and epidemiological evidence. Carcinogenesis 40(1),70-83.
7.
DaiN, ZhengM, WangC, et al.Genetic variants at 8q24 are associated with risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Sci, 2014; 105(6):731-735; doi: 10.1111/cas.12399
8.
DengS, RenZJ, JinT, et al.Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer. Medicine, 2019; 98(16):e15179; doi: 10.1097/md.0000000000015179
9.
DuvalS, TweedieR. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 2000; 56(2):455-463.
10.
EggerM, Davey SmithG, SchneiderM, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clin Res ed), 1997; 315(7109):629-634.
11.
ElsammanEM, FukumoriT, TanimotoS, et al.The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int, 2006; 98(3):668-673; doi: 10.1111/j.1464-410X.2006.06350.x
12.
FuYP, KohaarI, RothmanN, et al.Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk. Proc Natl Acad Sci U S A, 2012; 109(13):4974-4979; doi: 10.1073/pnas.1202189109
13.
García-GonzálezMA, BujandaL, QuinteroE, et al.Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease. Int J Cancer, 2015; 137(6):1362-1373; doi: 10.1002/ijc.29500
14.
Gonzalez-HormazabalP, Retamales-OrtegaR, MuslehM, et al.Polymorphisms PSCA rs2294008, IL-4 rs2243250 and MUC1 rs4072037 are associated with gastric cancer in a high risk population. Mol Biol Rep, 2020; 47(11):9239-9243; doi: 10.1007/s11033-020-05943-0
15.
GuZ, ThomasG, YamashiroJ, et al.Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene, 2000; 19(10):1288-1296; doi: 10.1038/sj.onc.1203426
16.
HellwigB, HengstlerJG, SchmidtM, et al.Comparison of scores for bimodality of gene expression distributions and genome-wide evaluation of the prognostic relevance of high-scoring genes. BMC Bioinform, 2010; 11:276; doi: 10.1186/1471-2105-11-276
17.
IchikawaH, SugimotoM, UotaniT, et al.Influence of prostate stem cell antigen gene polymorphisms on susceptibility to Helicobacter pylori-associated diseases: A case-control study. Helicobacter, 2015; 20(2):106-113; doi: 10.1111/hel.12183
18.
JoungJY, LeeYS, ParkS, et al.Haplotype analysis of prostate stem cell antigen and association with prostate cancer risk. J Urol, 2011; 185(6):2112-2118; doi: 10.1016/j.juro.2011.01.083
19.
JuYF, DiaoYQ, SongMQ et al. Relationship between rs2294008 polymorphism of PSCA gene and gastric cancer. Med J Qilu, 2015; 30(2):127-131.
20.
KadhumT, SelinskiS, BlaszkewiczM, et al.Impact on bladder cancer of 4 SNPs, related to the genes PSCA, FGFR3-TACC3 and CBX-APOBEC3A. Naunyn-Schmiedebergs Arch Pharmacol, 2021; 394(Suppl. 1):S40; doi: 10.1007/s00210-021-02066-6
21.
KeJ, ZhongR, ZhangT, et al.Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer. PLoS One, 2013; 8(4):e62485; doi: 10.1371/journal.pone.0062485
22.
KimSY, YooJY, ShinA, et al. Prostate stem cell antigen single nucleotide polymorphisms influence risk of estrogen receptor negative breast cancer in Korean females. Asian Pac J Cancer Prev, 2012; 13(1):41-48.
23.
KupcinskasJ, GyvyteU, BruzaiteI, et al.Common genetic variants of PSCA, MUC1 and PLCE1 genes are not associated with colorectal cancer. Asian Pac J Cancer Prev, 2015; 16(14):6027-6032; doi: 10.7314/apjcp.2015.16.14.6027
24.
KupcinskasJ, WexT, LinkA, et al. PSCA and MUC1 gene polymorphisms are associated with gastric cancer and pre-malignant gastric conditions [corrected]. Anticancer Res, 2014; 34(12):7167-7175.
25.
LeeIS, Pil SeoS, Sok HaY, et al.Genetic variation of the PSCA gene (rs2294008) is not associated with the risk of prostate cancer. J Biomed Res, 2017; 31(3):226-231; doi: 10.7555/jbr.31.20160072
26.
LeeJH, SongHR, KimHN, et al.Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population. Asian Pac J Cancer Prev, 2014; 15(20):8901-8904; doi: 10.7314/apjcp.2014.15.20.8901
27.
LiF, ZhongMZ, LiJH, et al. Case-control study of single nucleotide polymorphisms of PSCA and MUC1 genes with gastric cancer in a Chinese. Asian Pac J Cancer Prev, 2012; 13(6):2593-2596.
28.
LiM, YuX, ChengL, et al. Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer. Int J Clin Exp Med, 2015; 8(8):13259-13266.
29.
LiT, FanJ, WangB, et al.TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res, 2017; 77(21):e108-e110; doi: 10.1158/0008-5472.can-17-0307
30.
LochheadP, FrankB, HoldGL, et al.Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology, 2011; 140(2):435-441; doi: 10.1053/j.gastro.2010.11.001
31.
LuY, ChenJ, DingY, et al.Genetic variation of PSCA gene is associated with the risk of both diffuse- and intestinal-type gastric cancer in a Chinese population. Int J Cancer, 2010; 127(9):2183-2189; doi: 10.1002/ijc.25228
32.
MaY, XuYC, TangL, et al.Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: Efficacy and safety. Exp Hematol Oncol, 2012; 1(1):11; doi: 10.1186/2162-3619-1-11
33.
MaZ, HuQ, ChenZ, et al.Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol Carcinogen, 2013; 52(11):916-921; doi: 10.1002/mc.21932
34.
MatsudaK, TakahashiA, MiddlebrooksCD, et al.Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population. Human Mol Genet, 2015; 24(4):1177-1184; doi: 10.1093/hmg/ddu512
35.
MatsuoK, TajimaK, SuzukiT, et al.Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer, 2009; 125(8):1961-1964; doi: 10.1002/ijc.24519
36.
MocellinS, VerdiD, PooleyKA, et al.Genetic variation and gastric cancer risk: A field synopsis and meta-analysis. Gut, 2015; 64(8):1209-1219; doi: 10.1136/gutjnl-2015-309168
37.
MouX, LiT, WangJ, et al.Genetic variation of BCL2 (rs2279115), NEIL2 (rs804270), LTA (rs909253), PSCA (rs2294008) and PLCE1 (rs3765524, rs10509670) genes and their correlation to gastric cancer risk based on universal tagged arrays and Fe3O4 magnetic nanoparticles. J Biomed Nanotechnol, 2015; 11(11):2057-2066; doi: 10.1166/jbn.2015.2113
38.
OnoH, ChiharaD, ChiwakiF, et al.Missense allele of a single nucleotide polymorphism rs2294008 attenuated antitumor effects of prostate stem cell antigen in gallbladder cancer cells. J Carcinogen, 2013; 12:4; doi: 10.4103/1477-3163.109030
39.
OnoH, HiraokaN, LeeYS, et al.Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis. Genes Chromosom Cancer, 2012; 51(1):30-41; doi: 10.1002/gcc.20928
40.
OuJ, LiK, RenH, et al.Association and haplotype analysis of prostate stem cell antigen with gastric cancer in Tibetans. DNA Cell Biol, 2010; 29(6):319-323; doi: 10.1089/dna.2009.0960
41.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Syst Rev, 2021; 10(1):89; doi: 10.1186/s13643-021-01626-4
42.
QiaoL, FengY. Genetic variations of prostate stem cell antigen (PSCA) contribute to the risk of gastric cancer for Eastern Asians: A meta-analysis based on 16792 individuals. Gene, 2012; 493(1):83-91; doi: 10.1016/j.gene.2011.11.017
43.
QinZ, TangJ, LiX, et al.Association between PSCA gene polymorphisms and the risk of cancer: An updated meta-analysis and trial sequential analysis. Oncotarget, 2017; 8(31):51766-51778; doi: 10.18632/oncotarget.17011
44.
QiuLX, ChengL, HeJ, et al.PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population. Oncotarget, 2016; 7(8):9420-9428; doi: 10.18632/oncotarget.7137
45.
RaiR, SharmaKL, MisraS, et al.PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene, 2013; 530(2):172-177; doi: 10.1016/j.gene.2013.08.058
46.
ReiterRE, GuZ, WatabeT, et al.Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci U S A, 1998; 95(4):1735-1740; doi: 10.1073/pnas.95.4.1735
47.
RizzatoC, KatoI, PlummerM, et al.Genetic variation in PSCA and risk of gastric advanced preneoplastic lesions and cancer in relation to helicobacter pylori infection. PLoS One, 2013; 8(9):e73100; doi: 10.1371/journal.pone.0073100
48.
SaekiN, GuJ, YoshidaT, et al.Prostate stem cell antigen: A Jekyll and Hyde molecule?. Clin Cancer Res, 2010; 16(14):3533-3538; doi: 10.1158/1078-0432.ccr-09-3169
49.
SakamotoH, YoshimuraK, SaekiN, et al.Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Gen, 2008; 40(6):730-740; doi: 10.1038/ng.152
50.
SalaN, MunozX, TravierN, et al.Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC-EURGAST study. Int J Cancer, 2012; 130(10):2417-2427; doi: 10.1002/ijc.26243
51.
SmithC, LochheadP, BasavarajuU, et al.Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: A case-control and immunohistochemical study. BMC Res Notes, 2012; 5:371; doi: 10.1186/1756-0500-5-371
52.
SongHR, KimHN, PiaoJM, et al.Association of a common genetic variant in prostate stem-cell antigen with gastric cancer susceptibility in a Korean population. Mol Carcinogen, 2011; 50(11):871-875; doi: 10.1002/mc.20796
53.
SongQ, ZhuB, HuW, et al.A common SMAD7 variant is associated with risk of colorectal cancer: Evidence from a case-control study and a meta-analysis. PLoS One, 2012; 7(3):e33318; doi: 10.1371/journal.pone.0033318
54.
StangA.Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010; 25(9):603-605; doi: 10.1007/s10654-010-9491-z
55.
SunH, WuX, WuF, et al.Associations of genetic variants in the PSCA, MUC1 and PLCE1 genes with stomach cancer susceptibility in a Chinese population. PLoS One, 2015; 10(2):e0117576; doi: 10.1371/journal.pone.0117576
56.
SunY, GuJ, AjaniJA, et al.Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: A case-control study. Cancer, 2014; 120(19):3040-3048; doi: 10.1002/cncr.28792
57.
TangZ, LiC, KangB, et al.GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res, 2017; 45(W1):W98-w102; doi: 10.1093/nar/gkx247
58.
TurdikulovaS, DalimovaD, AbdurakhimovA, et al.Association of rs2294008 and rs9297976 polymorphisms in PSCA gene with gastric cancer susceptibility in Uzbekistan. Cent Asian J Glob Health, 2016; 5(1):227; doi: 10.5195/cajgh.2016.227
59.
WangM, WangX, FuSW, et al.Single-nucleotide polymorphisms in PSCA and the risk of breast cancer in a Chinese population. Oncotarget, 2016a;7(19):27665-27675; doi: 10.18632/oncotarget.8491
60.
WangP, YeD, GuoJ, et al.Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosom Cancer, 2014; 53(1):98-105; doi: 10.1002/gcc.22121
61.
WangS, TangJ, WangM, et al.Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Carcinogenesis, 2010; 31(4):621-624; doi: 10.1093/carcin/bgp323
62.
WangS, WuS, ZhuH, et al.PSCA rs2294008 polymorphism contributes to the decreased risk for cervical cancer in a Chinese population. Sci Rep, 2016b;6:23465; doi: 10.1038/srep23465
63.
WangT, ZhangL, LiH, et al.Prostate stem cell antigen polymorphisms and susceptibility to gastric cancer: A systematic review and meta-analysis. Cancer Epidemiol Biomark Prev, 2012; 21(5):843-850; doi: 10.1158/1055-9965.epi-11-1176
64.
WangZ, DaiJ, HuN, et al.Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: Pooled results from two Chinese genome-wide association studies. Gut, 2017; 66(4):581-587; doi: 10.1136/gutjnl-2015-310612
65.
WeiG, NiW, ChiaoJW, et al.A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol, 2011; 4:46; doi: 10.1186/1756-8722-4-46
66.
WuC, WangG, YangM, et al.Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinogen, 2009a;48(12):1131-1138; doi: 10.1002/mc.20565
67.
WuX, YeY, KiemeneyLA, et al.Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet, 2009b;41(9):991-995; doi: 10.1038/ng.421
68.
XuLP, QiuHB, YuanSQ, et al.Downregulation of PSCA promotes gastric cancer proliferation and is related to poor prognosis. J Cancer, 2020; 11(9):2708-2715; doi: 10.7150/jca.33575
69.
YanK, WuK, LinC, et al.Impact of PSCA gene polymorphisms in modulating gastric cancer risk in the Chinese population. Biosci Rep, 2019; 39(9):BSR20181025; doi: 10.1042/bsr20181025
70.
YangJ, LiW, ZhangZ, et al.PSCArs2294008 T polymorphism increases the risk of bladder cancer in Bai, Dai, and Han ethnicity in China and a potential mechanism. Genes Genom, 2018; 40(5):531-541; doi: 10.1007/s13258-018-0653-9
71.
ZengZ, WuX, ChenF, et al.Polymorphisms in prostate stem cell antigen gene rs2294008 increase gastric cancer risk in Chinese. Mol Carcinogen, 2011; 50(5):353-358; doi: 10.1002/mc.20718
72.
ZhangQH, YaoYL, GuT, et al. Association of the PSCA rs2294008 C>T polymorphism with gastric cancer risk: Evidence from a meta-analysis. Asian Pac J Cancer Prev, 2012; 13(6):2867-2871.
73.
ZhangW, LiangP, WangW, et al.The influence of PSCA gene variation on its expression and gastric adenocarcinoma susceptibility in the northwest Chinese population. Int J Mol Sci, 2015; 16(5):11648-11658; doi: 10.3390/ijms160511648
74.
ZhaoJ, GengP, LiZ, et al.Prostate stem cell antigen rs2294008 polymorphism differentially contributes to -negative gastric cancer among various populations in China. Mol Clin Oncol, 2013; 1(3):493-498; doi: 10.3892/mco.2013.70
75.
ZhaoK, LiX, WangJ, et al.Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma. Oncol Lett, 2018; 15(6):9151-9161; doi: 10.3892/ol.2018.8468
76.
ZhaoY, GuiZL, LiaoS, et al.Prostate stem cell antigen rs2294008 (C>T) polymorphism and bladder cancer risk: A meta-analysis based on cases and controls. Genet Mol Res, 2014; 13(3):5534-5540; doi: 10.4238/2014.July.25.7
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
